A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI
Status:
Unknown status
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
The PANACEA trial is an investigator-initiated prospective, single-center, two-arm,
non-blinded pilot randomized controlled trial of high-dose IV N-Acetylcysteine therapy used
as an adjunct to pharmaco-invasive reperfusion in patients presenting early after a large
STEMI.